Gilead Sciences Inc (GILD)
73.24
+0.23
(+0.32%)
USD |
NASDAQ |
Mar 28, 16:00
73.24
0.00 (0.00%)
After-Hours: 19:55
Gilead Sciences Total Liabilities (Quarterly): 39.38B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 39.38B |
September 30, 2023 | 40.13B |
June 30, 2023 | 41.24B |
March 31, 2023 | 40.94B |
December 31, 2022 | 41.96B |
September 30, 2022 | 41.50B |
June 30, 2022 | 42.66B |
March 31, 2022 | 43.16B |
December 31, 2021 | 46.89B |
September 30, 2021 | 45.63B |
June 30, 2021 | 48.27B |
March 31, 2021 | 48.53B |
December 31, 2020 | 50.19B |
September 30, 2020 | 43.41B |
June 30, 2020 | 37.79B |
March 31, 2020 | 37.56B |
December 31, 2019 | 38.98B |
September 30, 2019 | 38.41B |
June 30, 2019 | 40.46B |
March 31, 2019 | 40.75B |
December 31, 2018 | 42.14B |
September 30, 2018 | 41.30B |
June 30, 2018 | 43.62B |
March 31, 2018 | 44.73B |
December 31, 2017 | 49.78B |
Date | Value |
---|---|
September 30, 2017 | 39.41B |
June 30, 2017 | 37.17B |
March 31, 2017 | 36.78B |
December 31, 2016 | 37.61B |
September 30, 2016 | 39.25B |
June 30, 2016 | 33.86B |
March 31, 2016 | 33.75B |
December 31, 2015 | 32.60B |
September 30, 2015 | 32.69B |
June 30, 2015 | 22.53B |
March 31, 2015 | 20.73B |
December 31, 2014 | 18.84B |
September 30, 2014 | 14.98B |
June 30, 2014 | 14.78B |
March 31, 2014 | 14.38B |
December 31, 2013 | 10.83B |
September 30, 2013 | 11.28B |
June 30, 2013 | 11.28B |
March 31, 2013 | 11.82B |
December 31, 2012 | 11.70B |
September 30, 2012 | 12.21B |
June 30, 2012 | 12.42B |
March 31, 2012 | 12.59B |
December 31, 2011 | 10.44B |
September 30, 2011 | 6.407B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
37.56B
Minimum
Mar 2020
50.19B
Maximum
Dec 2020
42.39B
Average
41.37B
Median
Total Liabilities (Quarterly) Benchmarks
Amgen Inc | 90.92B |
Johnson & Johnson | 98.78B |
CymaBay Therapeutics Inc | 142.43M |
Arcus Biosciences Inc | 633.00M |
Moderna Inc | 4.572B |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 62.12B |
Shareholders Equity (Quarterly) | 22.83B |
Debt to Equity Ratio | 1.094 |
Current Ratio | 1.426 |
Net Debt Paydown Yield | 0.05% |